SHI Sverdlovsk Regional Clinical Hospital #1;Neurology
Ekaterinburg, Russian Federation
Psychiatric hospital in Yekaterinburg
Ulitsa Roshchinskaya, 72, Yekaterinburg, Sverdlovsk Oblast, 620023
About SHI Sverdlovsk Regional Clinical Hospital #1;Neurology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
AO GENERIUM
2
R-Pharm International, LLC
2
TauRx Therapeutics Ltd
2
Actelion
1
EMD Serono Research & Development Institute, Inc.
1
Genentech, Inc.
1
Janssen Pharmaceutica N.V., Belgium
1
Janssen Research & Development, LLC
1
Sandoz
1
Clinical Trials at SHI Sverdlovsk Regional Clinical Hospital #1;Neurology
During the past decade, SHI Sverdlovsk Regional Clinical Hospital #1;Neurology conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 6 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis
2008-07-17
2023-12-16
Active, not recruiting
220
Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients
2007-09-01
2010-01-01
Terminated
337
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
2011-12-01
2013-11-01
Completed
289
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
2013-01-01
2015-11-01
Completed
891
Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
2014-08-01
2017-05-01
Terminated
913
Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease
2016-05-01
2018-10-01
Completed
428
Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease
2016-05-24
2019-11-05
Completed
1,648
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "SHI Sverdlovsk Regional Clinical Hospital #1;Neurology" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "AO GENERIUM" with 2 trials
sponsored, "R-Pharm International, LLC" with 2 trials sponsored, "TauRx Therapeutics Ltd" with 2 trials sponsored and "Actelion"
with 2 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "SHI Sverdlovsk Regional Clinical Hospital #1;Neurology"
#1 collaborator was "OCT Clinical Trials" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "Mene Research" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at SHI Sverdlovsk Regional Clinical Hospital #1;Neurology
According to Clinical.Site data, the most researched conditions in "SHI Sverdlovsk Regional Clinical Hospital #1;Neurology" are
"Multiple Sclerosis" (3 trials), "Alzheimer's Disease" (2 trials), "Paroxysmal Nocturnal Hemoglobinuria" (2 trials), "Rheumatoid Arthritis" (2 trials) and "Anemia" (1 trials). Many other conditions were trialed in "SHI Sverdlovsk Regional Clinical Hospital #1;Neurology" in a lesser frequency.
Clinical Trials Intervention Types at SHI Sverdlovsk Regional Clinical Hospital #1;Neurology
Most popular intervention types in "SHI Sverdlovsk Regional Clinical Hospital #1;Neurology" are "Drug" (12 trials), "Biological" (2 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Ocrelizumab" (3 trials), "Antihistamine" (2 trials), "Methylprednisolone" (2 trials) and "Adalimumab 40mg q2w" (1 trials). Other intervention names were less common.
Clinical Trials Genders at SHI Sverdlovsk Regional Clinical Hospital #1;Neurology
The vast majority of trials in "SHI Sverdlovsk Regional Clinical Hospital #1;Neurology" are
14 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at SHI Sverdlovsk Regional Clinical Hospital #1;Neurology
Currently, there are NaN active trials in "SHI Sverdlovsk Regional Clinical Hospital #1;Neurology".
undefined are not yet recruiting,
4 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in SHI Sverdlovsk Regional Clinical Hospital #1;Neurology,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in SHI Sverdlovsk Regional Clinical Hospital #1;Neurology, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".